| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Fees and issuance costs from offering of common stock | 28 | 28 |
| Net cash provided by (used in) financing activities | -50,596 | -29,063 |
| Net decrease in cash, cash equivalents and restricted cash | -68,844 | -53,244 |
| Cash and cash equivalents at beginning of period | 221,276 | - |
| Cash and cash equivalents at end of period | 152,432 | - |
ASPEN AEROGELS INC (ASPN)
ASPEN AEROGELS INC (ASPN)